HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thoracoscopic sympathectomy is a valuable addition in the management of recreational intra-arterial drug injection. Pilot study.

AbstractBACKGROUND:
Intra-arterial Injection (IAI) of illicit substances by drug abusers may result in acute ischemia, limb loss or permanent functional deficit. No prospective human studies have shown that any specific treatment is superior to another. Thoracoscopic sympathectomy (TS) has proven efficacy in upper limb ischemia due to organic blockade. This is a pilot study to evaluate the effect of thoracoscopic sympathectomy addition to the management protocol of recreational intra-arterial drug injection.
PATIENTS AND METHODS:
A total of 11 victims of upper limb IAI of recreational drug were recruited (10 males) with age range from 18 to 43 years old (average 30+/-8.3 years). Tissue Ischemia Score (TIS) was used for pretreatment assessment of the degree of ischemic injury and severity of pain was evaluated pre- and post-operatively using visual analog score (VAS) and compared using Student's t test. Pre-operative VAS score was 6.9+/-1.8. All enrolled patients were treated according to the following protocol; anticoagulation, calcium channel blocker, opiates for pain, and TS. Patients received the stated protocol for minimum of 72h (range 3-8 days; mean 5; average 4.7+/-1.5 days). Freedom of amputation and improvement of pain scores were the study endpoints.
RESULTS:
No mortality, yet one case had bleeding secondary to anticoagulant and one case of post-operative pneumothorax that required chest tube drainage for 24h. No patients had wet gangrene or spreading infection. Freedom of amputation was achieved in nine patients, 81% (7 patients had normal outcome and other two had permanent neurological deficit). Two patients (18%) had tissue necrosis with dry gangrene and mummification of the affected digits with eventual amputation. Postoperative VAS pain score was 2.09+/-1.37 (p<0.05). Pain medications were suspended in 6 patients (54.5%), reduced in 4 (36%) and unchanged in 1 (9%). All patients with TIS score 2 or less had a normal outcome while those with scores 3 and 4 had a variable outcome. Using regression analysis, initial TIS was significant for outcome prediction (p=0.043) while age, arterial site, drug injected and time delay were not significant.
CONCLUSION:
The addition of TS was an attempt to halt the ischemic process after IAI which permitted, in our belief, optimal symptom control with maximum tissue salvage. Because the procedure is minimally invasive, safe, and associated with a low complication rate; it worth consideration whenever IAI is encountered.
AuthorsAyman El Samadoni, Ahmad Nada, Hisham Mostafa
JournalInternational journal of surgery (London, England) (Int J Surg) Vol. 8 Issue 3 Pg. 229-32 ( 2010) ISSN: 1743-9159 [Electronic] England
PMID20109590 (Publication Type: Journal Article)
CopyrightCopyright 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
Topics
  • Adolescent
  • Adult
  • Female
  • Humans
  • Injections, Intra-Arterial (adverse effects)
  • Ischemia (chemically induced, surgery)
  • Male
  • Pain Measurement
  • Pain, Postoperative
  • Substance-Related Disorders (complications)
  • Sympathectomy (adverse effects)
  • Thoracoscopy
  • Upper Extremity (blood supply, innervation)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: